✦ LIBER ✦

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

✍ Scribed by van Vollenhoven, Ronald F.; Fleischmann, Roy; Cohen, Stanley; Lee, Eun Bong; García Meijide, Juan A.; Wagner, Sylke; Forejtova, Sarka; Zwillich, Samuel H.; Gruben, David; Koncz, Tamas; Wallenstein, Gene V.; Krishnaswami, Sriram; Bradley, John D.; Wilkinson, Bethanie

Book ID: 119943080
Publisher: Massachusetts Medical Society
Year: 2012
Tongue: English
Weight: 557 KB
Volume: 367
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1112072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase IIb dose-ranging study of the oral

Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

✍ Roy Fleischmann; Maurizio Cutolo; Mark C. Genovese; Eun Bong Lee; Keith S. Kanik 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 4 views

Tofacitinib versus Methotrexate in Rheum

Tofacitinib versus Methotrexate in Rheumatoid Arthritis

✍ Lee, Eun Bong; Fleischmann, Roy; Hall, Stephen; Wilkinson, Bethanie; Bradley, Jo 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 487 KB

Placebo-Controlled Trial of Tofacitinib

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis

✍ Fleischmann, Roy; Kremer, Joel; Cush, John; Schulze-Koops, Hendrik; Connell, Car 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 639 KB

Tocilizumab versus adalimumab for rheuma

Tocilizumab versus adalimumab for rheumatoid arthritis

✍ Felson, David T 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 123 KB

Tocilizumab versus adalimumab for rheuma

Tocilizumab versus adalimumab for rheumatoid arthritis

✍ De Vita, Salvatore 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 442 KB

Adalimumab in rheumatoid arthritis

✍ Larry Moreland 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 121 KB